EXHIBIT 10.102
EMPLOYMENT
AGREEMENT
THIS EMPLOYMENT AGREEMENT
is dated as of March 23, 2009,
between Imaging Diagnostic Systems, Inc ., a Florida
corporation (the "Company"), and Linda B. Grable (the
"Executive").
WITNESSETH:
WHEREAS, The Company is engaged in the business of
developing laser-based medical optical imaging devices;
and
WHEREAS, the Company has the intent to market and sell
its products and services to clients and potential clients
throughout the world; and
WHEREAS , the Company wishes to employ the Executive as
its Chairman of the Board and Chief Executive Officer, to oversee
various broad and specific aspects of its business; and
WHEREAS , in the course of the Executive’s
employment, the Executive will have access to and acquire knowledge
of valuable trade secrets, confidential information and other
proprietary information belonging and relating to the Company and
its business, and which the Company has a legitimate interest in
protecting; and
WHEREAS , the Company and Executive are willing to
commit to such employment, subject to the terms and conditions
contained in this Employment Agreement (the
“Agreement”);
NOW, THEREFORE , in consideration of the premises and the
mutual covenants set forth in this Agreement, and intending to be
legally bound, the Company and the Executive agree as
follows:
1.
EMPLOYMENT . The Company hereby employs
the Executive and the Executive hereby accepts employment upon the
terms and conditions hereinafter set forth.
(a)
Term . The Company hereby employs the
Executive, and the Executive, hereby accepts employment with the
Company, for a period commencing on March 23, 2009, and ending one
year from that date (the "Term"). All Company obligations under
this Agreement shall cease upon its termination, except for those
stock options which have been vested. This employment
agreement supersedes the April 16, 2008 agreement except that the
1,000,000 options granted in that agreement continue and shall vest
on April 16, 2009.
(b)
Termination without Cause . The Company
may terminate the Executive’s employment without
cause. Such termination will become effective upon the
date specified in
the termination
notice, provided that such date is at least 60 days from the date
of such notice. In the event of such termination without
cause:
(i) For
the remainder of the Term following the effective date of
termination, the Company will continue to pay the Executive her
salary pursuant to Section 3(a).
(ii) The
Company will continue to maintain for the remainder of the Term
following the effective date of termination, for the benefit of the
Executive, the employee benefit programs referred to in Section
3(b) as in effect on the date of termination.
(iii) On
the effective date of termination, all options that were scheduled
to vest will vest and will remain exercisable for a period of three
years from the date of termination.
(c)
Termination for Cause . The Company may terminate
the Executive’s employment at any time for cause by giving
written notice of termination setting forth such
cause. Such termination shall become effective upon the
giving of such notice, except that, where the basis for cause is
capable of cure within 30 days, termination based upon cause shall
not become effective unless Executive shall fail to complete such
cure within 30 days of receipt of written notice of the existence
of such cause. Upon such termination the Executive shall have no
right to compensation, commission, bonus, benefits or reimbursement
pursuant to this Agreement, for any period subsequent to the
effective date of termination. Further, upon termination
for cause, all of the Executive’s unvested stock options
shall terminate. For purposes of this section, “cause”
shall mean; (1) the Executive is convicted of a felony; (2) the
Executive, in carrying out her duties hereunder, commits gross
negligence or willful misconduct resulting, in either case, in
material harm to the Company; (3) the Executive misappropriates
Company funds or otherwise defrauds the Company; (4) the Executive
materially breaches any provision of this Agreement; or (5) the
Executive materially fails to perform her duties under section
4.
(d)
Death or Disability . Upon the death or
disability of the Executive, the Executive shall be entitled to and
the Company will pay the Executive’s salary from the date of
death or from the date of disability through the end of the Term.
(For purposes of this Section, “disability” shall mean
that for a period of six months in any 12-month period the
Executive is incapable of substantially fulfilling her duties
because of physical, mental or emotional incapacity arising from
injury, sickness or disease.) Should the Executive be
rendered disabled, the Company will continue to maintain for the
benefit of the Executive the employee benefit programs referred to
in Section 3(b) that were in effect on the date of the
disability.
(e)
Special Termination . In the event that (i) the
Company materially breaches this Agreement or the performance of
its duties and obligations hereunder; or (ii) any entity or person
not now an executive officer of the Company becomes either
individually or as part of a group the beneficial owner of 20% or
more of the Company’s common stock, the Executive, by written
notice to the Company, may elect to deem the Executive’s
employment hereunder to
have been
terminated by the Company without cause under Section 2(b) hereof,
in which event the Executive shall be entitled to the compensation
provided for in Section 2(b).
(f)
Voluntary Termination . The Executive, on 30 days prior
written notice to the Company, may terminate her employment
voluntarily. Upon such termination, the Company will pay
the Executive’s compensation through the date of such
termination. After such date, the Executive shall no
longer be entitled to receive any compensation, reimbursement or
benefits and all unvested stock options shall terminate upon
termination of the Executive’s employment.
(g)
Continuing Effect . Notwithstanding any
termination of this Agreement at the end of the Term or otherwise,
the provisions of Sections 6 - 11 shall remain in full force and
effect and the provisions of these Sections shall be binding upon
the legal representatives, heirs, successors and assigns of the
Executive.
(a) The
Company will pay the Executive an annual base salary of $144,000
per annum in equal semi-monthly installments.
(b) During
the term of her employment, the Executive shall be entitled to
participate in employee benefits plans or programs of the Company,
if any, to the extent the Executive is eligible to participate
thereunder, including the Comprehensive Group Insurance Program
maintained by the Company, partially paid by the Company for the
Executive.
(c) The
Company shall provide the Executive with a $500 per month car
allowance and a cellular phone.
(d) The
Executive shall receive an option to purchase up to an aggregate of
3,000,000 shares of the Company’s common stock at an exercise
price of $.01 per share pursuant to the Company’s standard
form of stock option agreement. The option shall vest on
March 24, 2009, provided that the Executive remains employed by the
Company through that time, except to the extent that earlier
vesting is provided under specified circumstances as set forth
elsewhere in this Agreement or in the Company’s applicable
form of stock option agreement.
(e) The
Executive will be entitled to nine paid holidays and six weeks of
vacation for each 12-month period without loss of compensation or
other benefits to which she is entitled under this Agreement, to be
taken at such times as the Executive may select and the affairs of
the Company may permit.
(a)
General Duties . The Executive shall be employed
as the Chairman of the Board and Interim Chief Executive Officer,
with duties and responsibilities that are customary for such
position, and as directed by the Company’s
by-laws. The Executive will use the standard of care
befitting of such an executive in performing duties and in
discharging
responsibilities pursuant to this Agreement,
which duties and responsibilities shall be discharged competently,
carefully, and faithfully.
(b)
Corporate Code of Conduct . The Executive agrees
to adhere to the Company’s Corporate Code of
Conduct.
(c)
Extent of Services . The Executive will devote
all of her time, attention and energies during normal business
hours (exclusive of periods of sickness and disability and of such
normal holiday and vacation periods as have been established by the
Company) to the affairs of the Company. The Executive
will not enter the employ of, or serve as a consultant to, or in
any way perform any services with or without compensation to any
person, business or organization without the prior consent of the
Board of Directors of the Company; provided, that the Executive
shall be permitted to devote a limited amount of time, without
compensation, to charitable or similar organizations.
5.
PLACE OF PERFORMANCE . The Executive
hereby acknowledges that the Company’s existing and potential
clients are located throughout the world and that the Company is
actively engaged in marketing and selling its products and services
to such clients throughout the world.
6.
NON-DISCLOSURE OF CONFIDENTIAL INFORMATION .
The Executive acknowledges that, during her employment,
she will learn and will have access to confidential information
regarding the Company and its affiliates, including without
limitation (i) proprietary or secret plans, designs, processes,
programs, documents, software, agreements or material relating to
the business, products, services or activities of the Company and
its affiliates and (ii) market reports, customer investigations,
clinical data, scientific or engineering research, customer lists
and/or similar information that is proprietary information of the
Company or its affiliates (collectively, “Confidential
Business and Technical Information”). The
Executive recognizes and acknowledges that the Confidential
Business and Technical Information, as it may exist from time to
time, represents valuable, special and unique assets of the
Company, access to and knowledge of which are essential to the
performance of the Executive’s duties hereunder.
The Executive will not, during or after the term
of her employment by the Company, in whole or in part, disclose any
such Confidential Business and Technical Information to any person,
firm, corporation, association or entity for any reason or purpose
whatsoever, nor shall the Executive make use of any such
Confidential Business and Technical Information for her own
purposes or for the benefit of any person, firm, corporation or
entity except the Company under any circumstances during or after
the term of her employment, provided that after the term of her
employment these restrictions shall not apply to such secrets,
information and processes which are then in the public domain
provided that the Executive was not responsible, directly or
indirectly, for such secrets, information or processes entering the
public domain without the Company’s consent.
In the event an action is instituted and prior
knowledge is an issue, it shall be the obligation of the Executive
to prove by clear and convincing evidence that the
Confidential
Business and
Technical Information disclosed was in the public domain, was
already known by the recipient, or was developed independently by
the recipient. The Executive agrees to hold as the
Company’s property all memoranda, books, papers, letters,
formulas and other data, and all copies thereof and therefrom, in
any way containing Confidential Business and Technical Information
or otherwise relating to the Company’s business and affairs,
whether made by her or otherwise coming into her possession, and
upon termination of her employment, or on demand of the Company, at
any time, to deliver the same to the Company.
7.
NON-COMPETITION AGREEMENT .
(a) The
Executive acknowledges and agrees that, pursuant to Florida
Statutes Section 542.335, based on having access to and acquiring
knowledge of highly sensitive and valuable trade secrets, and
confidential or proprietary information belonging or relating to
the Company, the Executive would be in a position to cause serious
and irreparable harm to the Company in the event that, following
the termination of her employment hereunder, the Executive were to
compete with or be involved in an enterprise which competes with
the Company, engages in the same business as the Company, or
performs research and development in the field of medical optical
imaging.
(b) Until
termination of her employment and for a period of 24 months
commencing on the date of termination, the Executive, directly or
indirectly, in association with or as a stockholder, director,
officer, consultant, executive, partner, joint venturer, member or
otherwise of or through any person, firm, corporation, partnership,
association or entity, covenants that the Executive will not
compete with the Company or any of its affiliates in the design,
manufacture, construction, offer, sale or marketing of products or
services that are competitive with the products or services offered
by the Company during such period, within the United States or
anywhere in the world. The Executive covenants and
agrees that during her employment and for a period of 24 months
immediately following the termination of such employment, the
Executive will not, either individually or in partnership or
jointly or in conjunction with any person, firm, business,
corporation, partnership, joint venture, entity, syndicate or
association, as an executive, principal, agent, officer, director,
consultant, advisor, distributor, dealer, contractor, trustee,
lender, shareholder or in any manner or capacity whatsoever,
directly or indirectly, be employed by, render services to, carry
on or be engaged in, or be concerned with or be interested in or
advise, lend money to, guarantee the debts or obligations of, or in
any manner participate in the management, operation or control of
any business which is directly competitive with the business of the
Company, engages in the same business as the Company or performs
research and development in the medical optical imaging field with
any entity located anywhere in the world.
(c) For
the purposes of this paragraph a business shall be deemed to be in
“direct competition” or “directly
competitive” with the Company if such business is engaged in
developing, manufacturing, marketing, selling, or distributing
medical optical imaging devices.
8.
NON-SOLICITATION . The Executive
covenants and agrees that while she is employed by the Company and
for a period of 24 months immediately following the termination of
such employment, she will not, directly or indirectly, in any
manner whatsoever, on her own
behalf, or on
behalf of any person, firm, business, corporation, partnership,
joint venture, entity, syndicate or association solicit, induce or
cause, or attempt to induce or cause, any person who is then an
employee of or consultant to the Company to cease providing
services to the Company.
9.
REASONABLENESS OF CONFIDENTIALITY, NON-COMPETITION AND
NON-SOLICITATION OBLIGATION AND COVENANTS .
(a) The
Executive hereby acknowledges and confirms that the obligations and
covenants set out in the above paragraphs are reasonable and
necessary to protect the legitimate interests of the
Company. Without limiting the generality of the
foregoing, the Executive hereby acknowledges and confirms that
given, among other things, the nature and international scope of
the Company’s operations and of the employment duties to be
performed by the Executive hereunder, the geographic scope and
duration of the restrictions set forth above are reasonable and
necessary to protect the legitimate interests of the
Company.
(b) The
Executive further acknowledges and agrees that these obligations
and covenants will not preclude her from becoming gainfully
employed following their termination of her employment in her
profession.
|